PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | |hypertension |
| Sentences | 63 |
| PubMedID- 24759352 | The patient was diagnosed as having chronic liver disease with portal hypertension, with etiology probably related to non-alcoholic steatohepatitis (nash), with present decompensation due to drug-induced liver injury and sbp due to s. typhimurium. |
| PubMedID- 21561285 | Objective: hyperlipidemia, overweight, insulin resistance and hypertension are associated with non-alcoholic fatty liver disease. |
| PubMedID- 26029592 | Poph is defined as pulmonary arterial hypertension associated with liver disease and portal hypertension in the absence of other causes. |
| PubMedID- 25844525 | Analysis of peritoneal fluid was consistent with portal hypertension due to liver disease. |
| PubMedID- 26322515 | As shown earlier, elevated ggt levels are considered a marker for non-alcoholic fatty liver disease and are associated with diabetes, arterial hypertension and cardiovascular diseases [29, 30], [31]. |
| PubMedID- 24633023 | Conclusion: measuring the pft is effective for screening metabolic syndrome and evaluating diabetes, dyslipidemia and hypertension associated with fatty liver disease. |
| PubMedID- 21760840 | Pulmonary hypertension that develops in patients with liver disease and portal hypertension is called portopulmonary hypertension (ppht) [table 1]. |
| PubMedID- 26423996 | Most commonly, ectopic varices are caused by portal hypertension in the context of pre-existing liver disease (such as cirrhosis or hepatocellular carcinoma); albeit, other etiologies independent from portal hypertension do exist [1]. |
| PubMedID- 24616589 | Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease. |
| PubMedID- 21712949 | Further evaluation showed that he had chronic liver disease with portal hypertension and was hepatitis b surface antigen-positive, indicating hepatitis b infection. |
| PubMedID- PMC3239438 | The patient was suffering from advanced liver disease with portal hypertension and multiple current inter abdominal abscesses. |
| PubMedID- 20113491 | This fact is, nonetheless, expected since fatty liver disease does not lead to portal hypertension and, consequently, to the widening of the portal vein. |
| PubMedID- 22610002 | Background & aims: little is known about the prevalence and severity of portal hypertension in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 22623827 | He was a known case of alcoholic liver disease with portal hypertension categorised as child's class a. there was no visible caput medusae or audible periumbilical venous hum. |
| PubMedID- 24803978 | Portal hypertension due to chronic liver disease usually requires a longer period of time. |
| PubMedID- 22447257 | Pulmonary hypertension in patients with liver disease or portal hypertension can be due to multiple mechanisms, including hyperdynamic (high-flow) state, increased pulmonary venous congestion, and vascular constriction or obstruction of the pulmonary arterial bed. |
| PubMedID- 21196656 | Esophageal varices develop as a consequence of portal hypertension in patients with chronic liver disease and are present in approximately 50% of patients with cirrhosis of the liver. |
| PubMedID- 25148949 | [pulmonary hypertension in liver diseases]. |
| PubMedID- 25374709 | Hepatic myelopathy or porto-systemic myelopathy is a rare neurological complication of chronic liver disease with portal hypertension, usually associated with porto-systemic shunting, and presents as pure motor spastic paraparesis without sensory or sphincter involvement. |
| PubMedID- 22190914 | Reported that the accuracy of their string ece for diagnosing ev and portal hypertension in patients with chronic liver disease was excellent [23]. |
| PubMedID- 23812037 | Therefore, hscs can contribute to portal hypertension in patients with chronic liver disease (cld). |
| PubMedID- 24392231 | It occurs much more frequently in patients without underlying liver disease, but often leads to portal hypertension because the collateral veins are not able to adequately handle the splenic and mesenteric inflow. |
| PubMedID- 20065573 | Background/aim: esophageal varices (evs) are a serious consequence of portal hypertension in patients with liver diseases. |
| PubMedID- 24457056 | Aitp has been classified either as a primary autoimmune disorder or as secondary to a number of underlying conditions such as lymphoproliferative disorders, myelodysplasia, autoimmune collagen vascular diseases (e.g., systemic lupus erythematosus, antiphospholipid antibody syndrome) liver disease with portal hypertension, drugs or viral infection. |
| PubMedID- 21055685 | Hepatic granulomas may be manifested clinically by elevated levels of serum alkaline phosphatase and g-glutamyltransferase enzymes, damage to specific structures (eg, intrahepatic bile ducts in primary biliary cirrhosis), or infrequently, progressive liver disease with portal hypertension and cirrhosis (eg, sarcoidosis). |
| PubMedID- 23671546 | Exclusionary criteria were contraindications to wbv [43], severe cf (forced expiratory volume in 1 minute (fev1 < 40% predicted)), inability to stand unaided for 30 minutes, long bone or vertebral fracture in the past six months, past/present history of osteoarthritis, presence of cf-liver disease with portal hypertension, neuropathy or myopathy and/or vitamin d deficiency (25-hydroxyvitamin d < 39 nmol/l) in the past three months. |
| PubMedID- 25420739 | Variceal formation results from portal hypertension due to chronic liver disease. |
| PubMedID- 24613858 | Purpose of review: cirrhosis is the result of the progression of necroinflammatory liver diseases leading to fibrosis, portal hypertension, and a catabolic state, which might cause muscle wasting or sarcopenia. |
| PubMedID- 21229317 | Unfortunately, the patient had progressive biliary cirrhosis to end-stage liver disease complicated with portal hypertension for which she underwent successful orthotopic liver transplant at 7 years of age. |
| PubMedID- 24142390 | The insertion of a transjugular intrahepatic portosystemic shunt (tips) is a minimally invasive procedure used to relieve the signs and symptoms of portal hypertension in patients with liver disease. |
| PubMedID- 26201624 | Hepatic hydrothorax (hh) is an infrequent but a well-known complication of portal hypertension in patients with end-stage liver disease. |
| PubMedID- 20731173 | [pharmacokinetic and pharmacodynamic features of hypertensive drugs in treatment of patients with arterial hypertension associated with liver disease]. |
| PubMedID- 22973991 | Objectives: transient elastography (te), as a non-invasive method, has been studied for evaluation of portal hypertension in patients with chronic liver diseases (cld) with variable results. |
| PubMedID- 24714325 | As the patient has chronic liver disease along with portal hypertension, he has been referred for work up for liver transplantation. |
| PubMedID- 24171010 | The authors concluded that patients who carry the z allele are at greater risk (or, ≈ 5) of developing severe liver disease with portal hypertension (31). |
| PubMedID- 21813019 | To our knowledge, ha is the only serum marker that has been confirmed as an independent predictor of portal hypertension in patients with liver disease [20]. |
| PubMedID- 22059111 | In most cases, no evidence of liver dysfunction is observed, and portal hypertension due to sarcoid liver diseases is a rareoccurrence. |
| PubMedID- 21685145 | Background: a group of non-cirrhotic chronic liver diseases, all with sustained portal hypertension and clinically mistaken as cirrhosis, have been described under various names, apparently because of differences in pathological features. |
| PubMedID- 25147571 | The most common cause of colonic varices is portal hypertension associated with liver disease or secondary to pancreatic conditions, like chronic pancreatitis or malignancies. |
| PubMedID- 25885880 | Portopulmonary hypertension in liver disease presenting in childhood. |
| PubMedID- 23584902 | Portopulmonary hypertension (poph), a complication of chronic liver disease, may be a contraindication to liver transplantation (lt) because of the elevated risk of peritransplant and posttransplant morbidity and mortality. |
| PubMedID- 21280186 | End-stage liver disease with severe portopulmonary hypertension (pphtn), which is refractory to vasodilator therapies, is a contraindication for isolated liver transplantation (lt) because of the high mortality rate. |
| PubMedID- 22567478 | Significant morbidity is seen in those patients who develop complications such as end-stage renal diseases, chronic liver diseases with portal hypertension, and cancers associated with schistosomiasis [1–3]. |
| PubMedID- 21424236 | Portal hypertension in the setting of decompensated liver disease is managed medically (via endoscopy) or radiologically (via transjugular intrahepatic portosystemic shunt) with the aim to offer liver transplant as a permanent solution. |
| PubMedID- 22662598 | Clinical application of transient elastography in prediction of portal hypertension related complication in patients with chronic liver diseases. |
| PubMedID- 24796378 | Aim: liver fibrosis occurs as a result of several chronic liver diseases and leads to portal hypertension, cirrhosis and liver failure, often requiring liver transplantation. |
| PubMedID- 23123767 | Measuring spp using ultrasound is most simple and minimally invasive, and it might be useful for evaluating portal hypertension in dogs with liver diseases. |
| PubMedID- 24340101 | Two weeks after the surgery [28], the animal model of obstructive liver disease with portal hypertension was developed. |
| PubMedID- 25646812 | On the other hand, hiv coinfection accelerates hcv-related fibrosis progression [8] and increases the risk for developing end-stage liver disease (esld) [9] with portal hypertension and hepatocellular carcinoma (hcc) [10]. |
| PubMedID- 22270437 | Background: cirrhotic liver disease commonly is complicated by portal hypertension, and the resultant porto-systemic shunts are an important cause of morbidity and mortality in cirrhotic patients. |
Page: 1 2